The cardiac assist devices market is expected to grow at a CAGR of over 9% during the period 2022 To 2031.
The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population. With increased awareness of heart failures among patients and the availability of advanced treatment options, the market is likely to witness growth during the forecast period. The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. The introduction of less invasive devices by surgeons to perform left ventricular assist devices (LVAD) implant surgeries efficiently is leading to promising post-surgical outcomes. Moreover, the global cardiac assist devices market is likely to grow during the forecast period due to increasing technological advancements, new product approvals, increasing elderly population, improvements in reimbursement policies for heart failures, and associated comorbidities. Vendors are likely to focus on addressing unmet patient need as the demands for innovative cardiac assist devices is growing due to promising clinical outcomes, thereby increasing opportunities for vendors. The following factors are likely to contribute to the growth of the cardiac assist devices market during the forecast period: • Growing Global Incidence of Heart Failure • Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation • Increasing demand for Shared Care Centers & their Importance Post-LVAD Implantation • Technological Advancements • New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices The study considers the present scenario of the cardiac assist devices market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-91047 Global Cardiac Assist Devices Market: Segmentation This research report includes detailed segmentation by Application, Products, End-users, and Geography. The application of bridge to transplant (BTT) is enhancing the quality of life and survival chances of patients. The segment is expected to grow steadily due to advances in technology. The entry of advanced and innovative products from first-generation pulsatile flow cardiac assist devices to third-generation continuous flow devices is immensely influencing market growth prospects. However, the segment is likely to witness a decline during the forecast due to the increasing usage of cardiac assist devices as a destination therapy for treating advanced heart failure. Left ventricular assist devices (LVAD) are predominantly used to bridge to transplant and destination therapy compared to other devices. The usage of LVAD has significantly improved the survival rate among patients undergoing heart transplantation. The application of LVADs in patients requiring cardiac support for longer duration enhances the quality of life and survival chances. These factors are likely to influence patients to prefer LVAD implants, thereby bolstering the demand for LVADs. Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures. IABPs provide safer use and earlier intervention to provide hemodynamic support and has minimal complications than other cardiac assist devices. The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth. Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several CVDs, such as vascular stenosis and heart failure. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers. Market Segmentation by Application • Bridge to Transplant • Destination Therapy • Others Market Segmentation by Product • Intra-aortic Balloon Pump (IABP) • Ventricular Assist Devices (VADs) o Left Ventricular Assist Devices (LVADs) o Other VADs • Total Artificial Heart (TAH) Market Segmentation by End-user • Hospitals • Special Cardiac Centers Insights by Geography The North American market is expected to grow at the fastest CAGR due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments in such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries. The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. Favorable government policies and increased vendor initiatives in spreading awareness of stents are the other primary factors likely to influence the industry. Market Segmentation by Geography • North America o US o Canada • Europe o Germany o France o UK o Italy o Spain • APAC o Japan o China o India o South Korea o Australia • Latin America o Brazil o Mexico o Argentina • MEA o Turkey o Saudi Arabia Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-91047 Insights by Vendors The global cardiac assist devices market is highly consolidated with major players accounting for a significant share of the industry. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Moreover, they focus on expansion in existing and new industries to cater to the needs of the growing customer base, widen their product portfolios, and boost their production capabilities to gain traction from end-users. Leading players are likely to dominate the industry on account of their strong presence and surgeons’ endorsement for their products due to the availability of abundant clinical data and efficacy. Key Vendors • Abbott • Medtronic Other Vendors • Abiomed • Berlin Heart • Getinge • SynCardia • Teleflex • ZEON MEDICAL • Tokai Medical Products • SENKO MEDICAL INSTRUMENT • Insightra Medical • ReliantHeart • PulseCath • Jarvik Heart Key Market Insights The analysis of the cardiac assist devices market provides market sizing and growth opportunities for the period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecasts, and growth drivers in the market. • Includes a detailed analysis of challenges and investment opportunities in the industry. • Delivers a complete overview of market segments and the regional outlook of the cardiac assist devices market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key market strategies to gain a competitive advantage in the market.
0 コメント
The dental implants market is expected to grow at a CAGR of over 5% during the period 2022 - 2031.
The following factors are likely to contribute to the growth of the dental implants market during the forecast period: • Increasing Edentulous Patient Population • High Demand for Non-premium Dental Implants • Increasing Focus on Digital Dentistry • Growing Popularity of Dental Tourism • High Growth Potential of Ceramic Dental Implants Factors such as the increase in healthcare expenditure, awareness of oral hygiene, and usage of innovative oral care technology are expected to drive the dental implants market growth significantly. The prevalence of tooth decay among the geriatric population is high, which is further likely to bolster the demand for tooth replacement procedures. Dental caries is a major oral disease in emerging countries that affects 60–90% of school children and the majority of adults, thereby boosting the prospects of the market. There is increasing adoption of non-premium ones as they are cost-effective and are easily available in developed and developing countries, thereby stimulating growth opportunities. The growing prevalence of ceramic implants is increasing among patients worldwide ads they are corrosion-free and offer a higher success rate than metal ones, which is another primary factor driving the market. Hence, the increase in the adoption of advanced digital dentistry is boosting the market globally. The study considers the present scenario of the dental implants market and its market dynamics for the period 2022 To 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Download The Sample Report here: https://www.sdki.jp/sample-request-91043 Dental Implants Market: Segmentation This research report includes a detailed segmentation by design, cost, material, end-user, and geography. The demand for fully tapered implants is expected to increase in developed economies as consumers are increasingly adopting premium and advanced oral care implants, such as fully tapered. They are ideal for immediate placement and offer high stability and a low risk of labial perforation, thereby increasing growth prospects. The increased focus on R&D activities by vendors to develop fully tapered devices is also likely to have a significant impact on market growth. Moreover, cost-effectiveness and high recommendation from dentists are expected to increase the growth prospects. The increasing middle-income population and the growth in people requiring oral hygiene in emerging countries are expected to increase the demand for parallel-walled dental implants. Cost-effectiveness and ease of availability are the major factors influencing the segment. However, the segment is likely to grow at the slowest rate during the forecast period because parallel-walled implants cause damage to the jawbone, thereby increasing oral infection chances. The non-premium segment is expected to grow at the fastest CAGR during the forecast period on account of the decreasing adoption of premium tooth replacement procedures. The demand is likely to increase due to affordability and availability in developed as well as developing countries. Several leading vendors are expanding their non-premium dental implants portfolio by acquiring local and regional vendors, which is expected to influence the market positively. Moreover, the popularity of dental tourism is likely to increase the demand for non-premium procedures. People from the US and Canada are traveling to emerging countries such as Mexico and Brazil for tooth replacement due to the low-cost of denture implants. The adoption of premium implant types is likely to decrease as patients prefer low-cost procedures. Hence, the segment is likely to grow at the slowest CAGR during the forecast period. The ceramic segment is expected to grow at the fastest CAGR due to safe and non-allergic properties. The declining success rate of metal implants and the increase in the metal allergy population are expected to drive the usage of ceramic, which are likely to boost the segment. Moreover, increasing R&D activities from vendors to launch safe and high-quality implants are also expected to drive the market during the forecast period. The demand for metal ones is likely to diminish as they corrode and cause major oral complications, including the bone loss and severe inflammation of the surrounding gum tissue, thereby adversely hindering the growth of the segment. The increasing number of oral health clinics and the growing investments from governments in developed countries such as Canada, Japan, the US, and the UK are expected to increase denture implants procedures and bolster growth prospects. Patients with oral disorders increasingly prefer treatment at clinics as they offer personalized and specialized care. Moreover, large clinics are forming partnerships with the vendors, which are expected to help vendors to expand their distribution network and increase the demand for their products. Dental laboratories have a centralized manufacturing process, which helps to complete restoration procedures within a short period. These laboratories are equipped with high-end digital dentistry technologies such as CAD/CAM and digital radiography that help develop the impression of such procedures. Outsourcing of these impressions is expected to increase the market opportunity for oral care laboratories in emerging countries such as India and China, which are witnessing high private investments in these laboratories. Procedures such as dental implantations, basal implants, and tooth replacements are conventionally performed at hospitals. However, the segment is growing at the slowest CAGR as the majority of patients prefer specialized oral care clinics. Market Segmentation by Design • Parallel-walled Dental Implants • Tapered Dental Implants o Fully Tapered o Apically Tapered Market Segmentation by Cost • Premium Dental Implants • Non-premium Dental Implants o Value-based o Discounted Market Segmentation by Material • Metal Dental Implants • Ceramic Dental Implants Market Segmentation by End-user • Dental Clinics • Dental Laboratories • Hospitals • DSOs • Dental Academic Institutes Insights by Geography Europe is likely to dominate the market owing to high awareness of oral hygiene, coupled with improved healthcare infrastructure. Spain, Germany, Italy, Russia, and the UK are the major revenue generators in the region due to the availability of technologically advanced dental care products. Moreover, the increasing prevalence of periodontal disease in the geriatric population is expected to bolster the demand for dental implants. North America is likely to grow on account of increasing incidences of tooth loss in children and young adults due to the extensive consumption of sugar-rich foods. The growing prevalence of disorders is likely to boost demand in the region. Further, the development of advanced CAD/CAM technology and the presence of major vendors offering a diverse range of dental implants are the other primary factors expected to contribute toward growth. The availability of low-cost dental implants in APAC is likely to drive dental tourism and fuel market growth in the region. The growing number of public and private hospitals in the region is expected to lead to an increased volume of procedures in countries such as China and India. Further, the market is likely to grow due to the development of healthcare infrastructure, coupled with a growing awareness of dental implants among people. Market Segmentation by Geography • Europe o Spain o Germany o Italy o France o UK o Russia • North America o US o Canada • APAC o South Korea o China o Japan o Australia o India • Latin America o Brazil o Argentina o Mexico o Colombia • MEA o Iran o Turkey o Israel Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-91043 Insights by Vendors The global dental implants market is highly dynamic and diverse, with the presence of several global, regional, and local players offering a broad range of oral care products. Vendors with limited financial, operating, and marketing resources are expected to merge with leading players that can provide growth opportunities. Several key players strategize to acquire local companies to enhance their existing product and service offerings. The prospects of ceramic implants are likely to stimulate the appetite of strategic buyers and private equity firms. The market competitiveness is primarily based on pricing, innovation, technology, quality, reputation, and customer service. Vendors are focusing on developing and acquiring new products and technologies to remain competitive. The key strategies being followed by key players in the market are new product launches, product enhancements, M&As, and market expansions. Key Vendors • Institut Straumann • Dentsply Sirona • Zimmer Biomet • Henry Schein • Danaher • OSSTEM IMPLANT • Dentium Other Vendors • A. B. Dental Devices • ADIN Dental Implant Systems • Alpha-Bio • AVINENT • BEGO • Bicon • BIOTECH Dental • bredent medical • CeraRoot • Cortex Dental Implants Industries • Dentalpoint • Dentatus • Dyna Dental • Glidewell Laboratories • Southern Implants • Thommen Medical • SpiralTech Dental Implants • Sweden & Martina • TAV Dental • Vita - Zahnfabrik H. Rauter • TBR Implants Group • T-Plus Implant Tech • TRI Dental Implants • Z-Systems • ZEST Anchors Key Market Insights The analysis of the dental implants market provides sizing and growth opportunities for the period 2022 - 2031. • Offers market sizing and growth prospects of the market for the forecast period 2022 - 2031.. • Provides comprehensive insights on the latest industry trends, forecasts, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage. Multiparameter Patient Monitoring Devices Market - Global Outlook and Forecast 2022 - 20314/28/2022 The global multiparameter patient monitoring market is expected to grow at a CAGR of over 4% during the period 2022 - 2031.
The following factors are likely to contribute to the growth of the multiparameter patient monitoring market during the forecast period: • Growing Demand for Real-time Patient Monitors in Critical Care • Increasing Target Patient Population with Various Diseases • Rising Demand for Multi-parameter Patient Monitors in Home-care Settings • Growing Demand for Portable/Compact Multi-Parameter Monitors The global multiparameter patient monitoring market is likely to witness absolute growth because of the increasing application in hospitals, home care settings, and ambulatory surgery centers (ASCs). These devices are widely used in ICUs, emergency departments, and general wards to continuously monitor vital signs such as heart rate, blood pressure, and respiration rate. The introduction of advanced technologies, such as real-time, continuous, and remote patient monitoring (RPM), is expected to influence the market during the forecast period. Moreover, the increasing prevalence of chronic diseases and the increase in the elderly population are likely to be the major drivers for the multiparameter patient monitoring market. Globally, the prevalence of chronic diseases such as cancer is increasing at an alarming rate due to changing lifestyles, aging population, environmental pollutions, and increasing smokers; therefore, all these factors are expected to increase the demand for such devices. These devices are portable and do not hinder the mobility of patients and enable them to shift them within the ward or transfer from one hospital to another. Advanced healthcare infrastructure and favorable reimbursement policies allow a high adoption of these devices, thereby expecting to drive the market growth in developed economies during the forecast period. The study considers the present scenario of the global multiparameter patient monitoring market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-91037 Multiparameter Patient Monitoring Market: Segmentation This research report includes a detailed segmentation by devices, acuity level, patient group, end-user, and geography. The portable monitoring devices segment is likely to grow at the fastest CAGR during the forecast period. The ease of remotely monitoring and the availability of portable features are expected to increase their application in-home care settings and enable real-time vital signs monitoring. These devices reduce continuous monitoring costs and decrease frequent hospital visits. There has been increased adoption of advanced RPM platforms in the remote healthcare market. The demand for real-time, remotely, and continuous patient monitoring is adding new dimensions to the global telehealth market. Moreover, the usage of portable systems enables hospitals to shift the patient from intense care units to normal wards without switching off multiparameter patient monitor systems. The launch of advanced portable monitoring devices is likely to hinder the growth of fixed devices. Fixed monitors are majorly used in hospitals and ASCs. These devices limit the mobility of patients and are less preferred by healthcare providers. These types of devices have a high risk of losing data during power outages. Hence, these devices are less preferred and are expected to experience steady growth in the market. The high-acuity segment is likely to grow due to the growth in the occurrence of chronic diseases that require continuous monitoring. The demand for high-acuity monitors is expected to increase as patient monitoring in high-acuity conditions is a major priority for healthcare providers. However, these systems have a limitation due to restricted area usage and are only used in ICUs and operation theaters. Hence, there is a lower demand than low-acuity devices. The mid-acuity level is expected to grow at the slowest rate on account of the low availability of vendors offering such monitors. These types of monitors are used in ambulances, and the patient’s condition is unpredictable in such circumstances. Hence, ambulances prefer high-acuity monitors over mid-acuity, which is likely to impact the sale of these devices adversely. The low-acuity level segment is expected to grow at the fastest rate. The growth is majorly driven due to the low cost of low-acuity monitors, which is expected to bolster the demand for these devices from developed and developing regions. These monitors are portable and offer advanced features of RPM that enable healthcare professionals to monitor the patient continuously. Hospitals are likely to emerge as the major end-user for these advanced feature monitors due to their cost-effectiveness. The geriatric group segment dominates the segment and is expected to grow at the fastest rate because of the increasing elderly population that is vulnerable to chronic diseases and often requires immediate medical interventions. According to the WHO, there were around 962.3 million people aged 60 and above in 2017, and the number is expected to reach 2,080.5 million by 2050 globally, which is expected to impact the segment positively. The increasing number of premature births is likely to lead to the demand for pediatric multiparameter patient monitoring equipment. Around 15 million babies are born prematurely throughout the globe annually, and the number is growing YOY. These systems enable healthcare professionals to monitor heart rates, respiration levels, and vital organs to ensure the healthy growth of premature infants. The adult group segment is expected to grow gradually due to the increasing prevalence of chronic diseases such as diabetes, cancer, and asthma in the adult population. The change in lifestyle patterns, lack of physical activities, and the increasing work-related stress both in developed as well as developing countries are likely to promote the sales of these devices. The hospital segment is expected to grow during the forecast period due to the usage of patient monitoring devices in the emergency care setting, surgical units, and special wards to monitor the health condition regularly. The home care setting segment is expected to grow at a steady rate on account of the increasing awareness and adoption of home care monitoring systems. These devices enable to monitor vital signs at home and avoid regular hospital visits. This is considered to reduce hospital costs and help individuals to monitor their health regularly. Ambulatory surgery centers (ASCs) are likely to grow at the fastest rate as these centers are cost-effective and offer high-quality care with a minimal indirect treatment cost. Chronic disease patients that do not have insurance coverage are expected to prefer these healthcare settings over hospitals. The cost of surgeries in these centers is also significantly low than in hospitals. Hence, the demand for same-day discharge (SDD) procedures is rapidly increasing, and the demand for access to multiparameter patient monitoring devices is likely to increase in these centers. Market Segmentation by Devices • Portable/Compact • Fixed Market Segmentation by Acuity Level • High Acuity • Mid Acuity • Low Acuity Market Segmentation by Patient Group • Geriatric Group • Adult Group • Pediatric Group Market Segmentation by End-user • Hospitals • ASCs • Homecare Settings • Others Insights by Geography In 2019, North America dominated the market. The region is expected to grow at a steady pace due to the increasing old age population, the moderate increase in the ICU admission, and the availability of advanced technology for RPM. The presence of a large pool of population with several chronic diseases, coupled with high acceptance of advanced and innovative multiparameter patient monitoring devices, is likely to support the region’s dominance in the global market. Europe is expected to gradually grow on account of the rising incidence of chronic diseases. There are likely to be more than 50 million people in Europe having more than one chronic disease. Germany, France, the UK, Italy, and Spain are the major revenue contributors to the European market. The high awareness levels of the availability of multiparameter monitoring devices, an increase in R&D investment for the development of innovative devices, and growing technological advancements in new product approvals/launches are expected to offer a positive impact on growth during the forecast period. The APAC region is expected to witness rapid growth during the forecast period. India and China together have a significant population with chronic diseases such as cancer and diabetes. The incidence of cancer in China and India was 4,285,033 and 1,157,294, respectively, in 2018. China is the major revenue contributor to the multiparameter patient monitoring market in APAC. Japan, India, South Korea, and Australia are expected to witness the significant growth rate because of the rise in healthcare expenditure and favorable public and private initiatives for an increase in healthcare access. Market Segmentation by Geography • North America o US o Canada • Europe o Germany o France o UK o Italy o Spain • APAC o Japan o China o India o South Korea o Australia • Latin America o Brazil o Mexico o Argentina • MEA o Turkey o Saudi Arabia o South Africa Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-91037 Insights by Vendors The market is highly competitive and characterized by the presence of global, regional, and local players offering multi-parameter patient monitoring devices. Key players are expected to maintain a strategic focus on North America and Europe as they are the top two major revenue contributors. Leading players are likely to focus on expanding portable/compact multiparameter monitors product portfolio as the demand for such devices is expected to increase among end-users. Local manufacturers, in particular, Chinese and Japanese manufacturers, are expected to offer stiff competition to global players. The market is likely to witness technological advancements and significantly affect new product launches. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are expected to invest extensively in R&D and product development related activities. Key Vendors • NIHON KOHDEN • Koninklijke Philips • OSI Systems • Shenzhen Mindray Bio-Medical Electronics • GE Healthcare Other Vendors • Contec Medical Systems • Drägerwerk • AS-Motor • EPSIMED • GUANGDONG BIOLIGHT MEDITECH • Kizlonmedical • Lutech Industries • Mediana • MEDION HEALTHCARE • Opto Circuits (India) • SCHILLER • Skanray Technologies Key Market Insights The analysis of the multiparameter patient monitoring market provides sizing and growth opportunities for the forecast period 2022 - 2031. • Offers sizing and growth prospects of the multiparameter patient monitoring market for the forecast period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the multiparameter patient monitoring • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2022 To 2031.
The following factors are likely to contribute to the growth of the transplant diagnostics market during the forecast period: • Growing Number of Transplantations & Prevalence of Chronic Diseases • Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients • Emergence of cfDNA in Transplant Diagnostics • Increasing Focus on Identifying New Biomarkers for Minimizing Transplantation Rejection The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate. The study considers the present scenario of the global transplant diagnostics market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Request The Sample Report Here: https://www.sdki.jp/sample-request-91028 Transplant Diagnostics Market: Segmentation This research report includes detailed market segmentation by product, application, technology, transplantation type, end-user, and geography. The increasing usage of a wide array of reagents and test kits to perform transplant diagnostics tests is a significant factor affecting the growth of the reagents & consumables product segment. The segment is growing at a faster rate than the instruments & software product segment due to their recurring purchase by end-users for performing molecular and non-molecular transplant tests. The growth in technological advancements such as NGS and PCR-based molecular testing techniques is another factor driving the adoption of molecular transplant assays, test kits, and reagents. The instruments and software segment is growing due to the rise in organ and tissue transplantations and the adoption of advanced techniques. The segment is growing at a relatively slow pace than the consumables & test kits segment as it is capital intensive, and purchasing decisions for these equipment depend on financial resources and budget allocations. However, the recent trends in automation and integration of several medical platforms have led to the introduction of innovative transplant diagnostic analyzers, thereby driving the growth of the segment. The research application segment is likely to witness faster growth than the clinical application segment as the number of research activities and clinical trials related to transplantation, especially stem cells, is increasing worldwide. The increase in the number of clinical trials and ongoing research activities to improve clinical outcomes is encouraging end-users to effectively screen donors and recipients, perform compatibility assessments and diagnose complications such as organ rejection and infections using molecular and non-molecular tests. The diagnostics applications segment is growing at a healthy rate and is expected to grow during the forecast period. Transplantation is the treatment of choice for several patients with end-stage organ failure diseases. Significant signs of progress have been achieved both in short-term outcomes and long-term graft survival due to the increasing availability of molecular and serological-based tests to monitor transplant patients. Hence, technological improvements have further increased the application of the segment. The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the segment. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment. Advances in serology and cellular assays have broadened the scope of transplant immunology technologies. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Their potential in antibody-based histocompatibility tests, especially for lymphocyte micro cytotoxicity testing, has been fueling the demand. Several vendors are offering non-molecular testing products, which is further contributing to the growth. Solid-organ transplantation has become vital in treating patients suffering from terminal illnesses. Therefore, the global number of solid organ transplantations is increasing at a healthy rate despite interruptions in the organ donation supply mechanism. Incidences of end-stage organ failures are high among patients with chronic diseases, thereby increasing the need for solid organ transplantations. The growth in hematological cancer cases is a key factor for the increasing demand for stem cell therapy worldwide. Standard reference laboratories conduct tests to identify donor receiver compatibility pre-transplantation. As the number of organs, cells, and tissue replacements is growing worldwide, the demand for laboratory testing is likely to rise at a steady rate. Government financial support for these laboratories is another major factor for the growth of the segment. Academic institutes & research laboratories end-users are growing at a healthy rate as these centers conduct research studies for evaluating the efficacy and safety of immunosuppressive therapies for organs, cell, and tissue replacements. Healthcare professionals in hospitals and transplant centers use various instruments, accessories, and software for conducting pre and post-transplantation diagnostics tests. The market is growing at a healthy rate due to the adoption of advanced instruments accessories and software for organs, cells, and tissue transplantations. The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers. Also, favorable reimbursement for transplant diagnostics is another factor boosting the end-user segment. Market Segmentation by Product • Instruments & Software • Consumables & Test Kits Market Segmentation by End-user • Standards Reference Laboratories • Hospitals and Transplant Centers • Research and Academic Centers Market Segmentation by Transplant Type • Solid Organs • Soft Tissues Market Segmentation by Technology • Molecular • Non-molecular Market Segmentation by Application • Diagnostic • Research Insights by Geography The presence of a large pool of the patient population with terminal diseases and the high acceptance of advanced and innovative molecular procedures for transplant diagnostics have collectively supported the growth. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The availability of highly sophisticated healthcare infrastructure and high awareness of advanced transplant procedures are contributing to the growth during the forecast period. The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC. The region is expected to witness significant growth due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives. Market Segmentation by Geography • Europe o Spain o France o Germany o UK o Italy • North America o Canada o US • APAC o China o Japan o South Korea o India o Australia • Latin America o Brazil o Argentina o Mexico • MEA o Saudi Arabia o Iran o South Africa o Israel Download The Sample Report Here: https://www.sdki.jp/sample-request-91028 Insights by Vendors The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2022. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally. Key Vendors • Thermo Fisher Scientific • Hoffmann-La Roche • bioMérieux • Bio-Rad Laboratories • QIAGEN • Immucor Other Vendors • BAG Diagnostics • CareDx • ELITechGroup • Genome Diagnostics • Illumina • NanoString Technologies • Omixon • Transplant Genomics • Wakunaga Pharmaceutical Key Market Insights The analysis of the transplant diagnostics market provides sizing and growth opportunities for the forecast period 2022 - 2031. • Offers sizing and growth prospects of the transplant diagnostics market for the forecast period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecasts, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the transplant diagnostics market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain a competitive advantage. The orthopedic mattress market is expected to grow at a CAGR of over 2% during the period 2022 To 2031.
The following factors are likely to contribute to the growth of the orthopedic mattress market during the forecast period: • Increase in Disposable Income and Rapid Urbanization • Growth of Real Estate Sector • Increasing Demand for Eco-Friendly Mattresses • Awareness of Good Sleep The global orthopedic mattress market is in the nascent growth stage; however, it is expected to grow exponentially during the forecast period. Sound sleep is recognized as an essential factor for good health and body, thereby increasing efficiency and the quality of life. As people are becoming health conscious, the increased awareness of good sleep and sleeping postures is likely to drive the demand for high-quality orthopedic bed mattress. The growing demand for eco-friendly orthopedic mattresses is another key trend witnessed in the market. They are made of non-toxic materials, including organic cotton, organic wool, and organic latex. As the disposal of mattresses has emerged a major environmental hazard across the globe, the demand for biodegradable and sustainable materials is gaining traction. Manufacturers are increasingly shifting to materials that are easy to dispose of. The growing awareness of proper sleep postures and back and spine-related disorders is expected to develop opportunities for manufacturers across the world. Moreover, the increasing number of ortho surgical procedures is also influencing product demand. Developed countries such as North America and Europe are witnessing a rapid adoption due to the growing number of back disorders and high acceptance of innovative beds. The study considers the present scenario of the orthopedic mattress market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Request The Sample Report Here: https://www.sdki.jp/sample-request-91025 Orthopedic Mattress Market: Segmentation This research report includes detailed segmentation by product type, distribution type, end-user type, and geography. Low-cost availability and affordability of open coir and spring mattresses have enhanced their acceptability in Europe, North America, and MEA regions, thereby driving the segment. Pocket spring orthopedic mattresses offer individual comfort and support by causing less partner motion disturbance. Therefore, they are observing high demand, which is expected to continue during the forecast period. The market share of the non-spring segment is over 50% owing to the advantages such as maintaining body temperature and distributing the bodyweight evenly, which helps to reduce back pains. The market is expected to be driven by macro and microeconomic factors, unorganized market conditions, strong conventional offline channels, and the demand for coir-based beds from the APAC region. The demand for an orthopedic memory foam mattress is higher than for other types. The demand is high in the residential sector and is likely to grow during the forecast period on account of the rise in residential construction. Increased awareness of proper sleeping postures in the population is driving demand. In addition, stability in the economic landscape, an increase in disposable incomes, and the rise in orthopedic ailments are likely to impact the market. The availability of inexpensive raw materials in APAC is another factor influencing the demand. The US residential market has been witnessing the demand for spring orthopedic mattresses, whereas MEA and APAC regions prefer non-spring ones. The offline distribution segment accounts for over 80% of the share as most of the customers prefer to purchase from brick and mortar stores. However, the online segment has gained momentum in recent years and is likely to grow during the forecast period due to the increasing internet penetration, which has increased the awareness of orthopedic mattresses. Also, factors such as cost, product features, brand reputation, and post-sale services are likely to increase the share of the online segment. Market Segmentation by Product Type • Spring o Open Coil/Open Spring o Continuous Spring o Pocket Spring • Non-Spring o Latex Foam o Memory Foam o Polyurethane Foam o Others Market Segmentation by Distribution Type • Offline • Online Market Segmentation by End-user Type • Residential • Commercial Insights by Geography The global orthopedic mattress market is largely concentrated in the North American region with an estimated value of over 20%. This region has seen a rise in the number of sleep disorders among adults. Hence, the increasing awareness of proper sleep postures is growing, which is expected to drive the market. Another factor, which plays a crucial role in the growth, is the increasing number of knee and hip replacement surgeries. In Europe, the demand for a plant-based orthopedic foam mattress is increasing rapidly as they are eco-friendly. This region also has a high acceptance of the latest technologies, which result in the introduction of bed-in-a-box mattresses. This has developed business opportunities for online players to penetrate the market. The increase in the aging population and the rise in ortho ailments in the APAC region have rapidly increased the demand for orthopedic beds. Market Segmentation by Geography • APAC o China o Japan o Australia o India o South Korea • Europe o Germany o UK o France o Italy o Spain • North America o US o Canada • Latin America o Mexico o Brazil o Argentina • MEA o Turkey o Saudi Arabia o South Africa o Egypt o UAE Download The Sample Report Here: https://www.sdki.jp/sample-request-91025 Insights by Vendors The orthopedic mattress market is characterized by intense competition with many global and regional manufacturers in both domestic and global markets. The entrance of online players has relatively increased competition in the market. Vendors are focusing on innovative products and technologies such as bed-in-a-box type mattresses. They are also aiming to develop the product portfolio, which is expected to help in increasing shares. Manufacturers are competing by launching products at regular intervals at competitive prices. Key vendors in North America and Europe dominate the ortho mattress market; however, regional and local vendors are finding it difficult to compete with global players. In the APAC region, major vendors are facing stiff competition from unorganized players. Key Vendors • Spring Air • Serta Inc • Illinois Sleep Products • SilentNight Mattress • Sealy Mattress • King Koil Mattress • Relyon Other Vendors • Hiding Anders • Corsicana • MLILY • BedKing Direct • Durfi Mattress • Flo Mattress • Wake Fit Key Market Insights The analysis of the orthopedic mattress market provides sizing and growth opportunities for the forecast period 2022 - 2031. • Offers sizing and growth prospects of the market for the forecast period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecasts, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage. The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2022 To 2031.
The following factors are likely to contribute to the growth of the HPV testing market during the forecast period: • Increasing Prevalence of HPV Infections • Emergence of Point-of-care Diagnostics/Rapid HPV Tests • Rise of mRNA Test for Cervical Cancer Screening • Increasing Demand for HPV Co-testing The increased procurement of the latest-generation HPV testing analyzers and test kits, coupled with the high prevalence of HPV-related infections and cancers, especially cervical and vaginal, influences the growth of the global HPV testing market. Traditionally, cervical cancer screening was based on cervical cytology. However, in recent years, several countries and global health bodies have recommended the inclusion of HPV tests in cervical and pre-cancer screening programs, which is likely to boost the market. The demand for new innovative testing consumables and instruments using advanced techniques such as the HPV mRNA test, which promotes accurate and sensitive diagnostic outcomes, is driving the market growth. Further, with the availability of positive clinical evidence, demonstrating the superiority of the latest generation advanced testing devices, end-users will become increasingly aware of clinical benefits and rapidly adopt these tests as an essential screening tool for cervical cancer screening. Therefore, the improvement in patient management, favorable government initiatives for primary screening, and the rising awareness of advanced testing in developed and developing economies are increasing the adoption globally. The study considers the present scenario of the HPV testing market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-91022 HPV Testing Market: Segmentation This research report includes detailed segmentation by products, applications, end-user, and geography. The consumables segment is growing due to the high adoption of advanced testing kits, reagents, and other related consumables to detect and screen cervical cancers globally. The segment is also growing at a fast rate due to the recurring purchase by end-users to perform HPV tests. These screening tests are likely to gain wide acceptance in emerging economies due to favorable government initiatives and the rise in consumer spending power. Therefore, market players are focusing on significant product launches in a low-resource setting of emerging countries, thereby accelerating the segment growth. The instruments segment is growing at a slow pace as the procurement of analyzers is capital intensive and the purchasing decision depends on financial resources and budget allocations. However, the increasing availability of automated and compact analyzers/instruments has significantly improved the efficiency and quality of end-user operations. Automation and integration of several diagnostic platforms have led to the introduction of innovative diagnostic analyzers, thereby driving the growth during the forecast period. The cervical application segment is growing on account of the rise in cervical cancer incidences. The increased focus of market players to launch screening products in low-resource countries is expected to drive the cervical application segment during the upcoming years. HPV self-sampling is emerging with the rapid availability of these devices as a potential screening strategy, especially in the US, which is likely to contribute to the growth. The application of HPV testing for vaginal cancer offers powerful negative predictive values. Therefore, the detection of infection with a high-risk HPV, which produce visible signs, is a powerful tool for vaginal cancer screening. Owing to the benefit of HPV testing, coupled with the rise in the vaginal cancer burden globally, vendors are offering innovative testing devices, which are driving the growth of the vaginal application segment. The increased focus on enhancing the sensitivity of cervical screening to reduce false-negative diagnoses as well as improve the specificity of molecular tests to detect high-risk human papillomavirus is a major factor contributing to the growth of standard reference laboratories. The availability of standard reference laboratory services for the evaluation of HPV DNA and antibody detection in biological specimens through capacity-building worldwide is another reason for the growth of standard reference laboratories. Healthcare professionals in hospitals use human papillomavirus testing as a screening procedure for the cervical and other related cancers. The market is likely to grow at a fast pace during the forecast period on account of the adoption of advanced testing products. A majority of patients with high-risk symptoms prefer visiting hospitals for diagnosis due to advanced infrastructure facilities available in major private and public hospitals. The physicians’ office and clinic segment is expected to grow mainly on account of the growing prevalence of cervical cancers worldwide. These clinics perform laboratory screening through private offices for people with a high risk of cervical and other HPV associated cancers at an affordable cost. Another factor responsible for the rise of this segment is the availability of super-specialty expertise in these clinics. Market Segmentation by Products • Consumables • Instruments Market Segmentation by Applications • Cervical Cancers • Vaginal Cancers • Others Market Segmentation by End-user • Standard Reference Laboratories • Hospitals • Physicians’ Office and Clinics Insights by Geography North America is growing at a significant rate due to the growing preference for HPV tests to detect and screen cervical cancers and other related infections. The presence of a large pool of population with a high risk of developing cervical cancer, the increasing acceptance of HPV testing, and growing awareness of advanced testing procedures have accelerated the market. Germany, France, the UK, Spain, and Italy are the leading contributors to the Europe market. The presence of highly sophisticated healthcare infrastructure, a high awareness level of advanced HPV screening procedures with high analytic sensitivity for detecting cervical cancers, and increased investment in R&D activities are the major drivers for the growth in the region. The region has the largest population density and the highest population with a high risk of developing cervical cancers and other associated infections. Japan, China, Australia, South Korea, and India are the major revenue contributors from the region. Japan is the major revenue contributor to the HPV testing market in APAC due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives for an increase in the healthcare access. Market Segmentation by Geography • North America o US o Canada • Europe o Germany o France o UK o Spain o Italy • APAC o Japan o China o India o South Korea o Australia • Latin America o Brazil o Mexico o Argentina • MEA o Turkey o South Africa o Saudi Arabia Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-91022 Insights by Vendors The global HPV testing market is highly competitive and characterized by the presence of several global, regional, and local players. F. Hoffmann-La Roche, QIAGEN, Hologic, and Abbott are the dominant players, and their testing instruments and consumables are widely used by end-users globally. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities. Over the years, these players have been dominating the market as they have introduced safe and efficient products in the market. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market. Key Vendors • Hoffmann-La Roche • QIAGEN • Hologic • Abbott Other Vendors • Arbor Vita • BD • Cepheid • DAAN Gene • DiaCarta • Fujirebio • Greiner Bio One International • Hybribio • IncellDx • Norgen Biotek • PreTect • Seegene • Siemens Healthineers • Takara Bio • Xiamen Zeesan Biotech • ZYTOVISION Key Market Insights The analysis of the global HPV testing market provides sizing and growth opportunities for the forecast period 2022 - 2031. • Offers sizing and growth prospects of the market for the forecast period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage. The cardiac pacemaker market is expected to grow at a CAGR of over 2% during the period 2022 - 2031.
The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to cardiac arrhythmias, is expected to drive the global cardiac pacemaker market. Advancements in technology and engineering provide clinicians innovative ways to care for the aging population. Cardiac pacing, particularly, has witnessed a series of game-changing technologies in the past several years spurred by low-power electronics, high-density batteries, and innovative software designs. Such innovations are expected to drive the cardiac pacemaker market. The global cardiac pacemaker market is witnessing rapid technological advancements and is significantly affected by new product launches. All the companies that primarily derive revenue from cardiac pacemakers are expected to grow at a positive rate. Multiple product launches and a diversified product portfolio are likely to fuel their growth in recent years. The global cardiac pacemaker market is likely to post an incremental growth of over $500 million by 2031. North America dominates the global market with over 30% revenue share, is expected to continue its dominant position during the forecast period. APAC is expected to grow at a faster rate, with a CAGR of over 4% during the period 2022 - 2031. Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-91016 The following factors are likely to contribute to the growth of the cardiac pacemaker market during the forecast period: • Increasing Demand for MRI-conditional Cardiac Pacemakers • Technological Advancements & Increasing Focus on Product Innovations • Increase in Target Patient Population with Cardiac Arrhythmias • Increasing Demand for Wireless & Automated Pacemakers Integrated with Remote Monitoring The study considers the present scenario of the cardiac pacemaker market and its market dynamics for the period 2022 - 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market. Cardiac Pacemaker Market: Segmentation This research report includes detailed segmentation by products, technology, implantability, end-user, and geography. The MRI-conditional segment accounted for over 50% of market revenue share in 2022 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted with pacemakers require MRI scan during their lifespan. Many public organizations recommend implanting MRI-conditional ones to minimize the risk associated with MRI scans. Moreover, several public and private insurance companies offer reimbursement coverage for MRI scans for patients implanted with MRI-conditional devices, which increases affordability thereby driving the market. Advancements in technology are influencing the market positively as traditional pacemakers are expected to malfunction, thus leading to complications. Hence, the increased complications related to traditional devices are likely to decrease the share of this equipment. Dual-chamber technology is accounted for the major share. This type of technology is likely to continue its dominance due to the increasing number of patients with abnormal heart rhythm defects. These models are highly efficient in treating cardiac arrhythmias. Besides, the number of vendors offering such pacemakers is growing as many patients prefer this type. Biventricular cardiac pacemakers/CRT-P is growing at a rapid pace as these devices minimize heart failure chances and efficiently treat rhythm disorders. All these advantages, along with increased public and private reimbursement coverage, are expected to boost the segment. Implantable pacemakers are growing at a rapid pace due to the increase in the geriatric population and the rise in arrhythmia and abnormal cardiovascular disorder prevalence rates. Advancements in technology, including the introduction of leadless, MRI-compatible, and other remote monitoring pacemaker devices have fueled the demand for implantable ones, and the segment is expected to contribute significantly to the market. External pacemakers are expected to grow at a steady pace due to the increased number of patients opting for temporary cardiac devices. Hospitals are the major end-user segment as a significant number of patients prefer to undergo surgeries in these settings due to better reimbursement policies. The growing aging population and the increasing prevalence of abnormal cardiovascular disorders are the other major factors contributing to the increase in implantation in hospitals. Market Segmentation by Product • MRI-conditional Pacemakers • Traditional Pacemakers Market Segmentation by Technology • Dual Chamber Pacemakers • Single Chamber Pacemakers • Biventricular Pacemakers/CRT-P Market Segmentation by Implantability • Implantable Pacemakers • External Pacemakers Market Segmentation by End-user • Hospitals • Specialty Cardiology Centers • ASCs Insights by Geography North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations. Europe is likely to grow at a healthy rate due to the accessibility of advanced healthcare services, especially for heart valve repair and replacement procedures. Also, the increasing incidence of abnormal heart rhythm, the rapid adoption of advanced cardiac pacemakers, and high healthcare expenditures are projected to increase the European market. Factors responsible for the growth of APAC are vendors’ initiatives in spreading awareness and the rise in abnormal rhythm incidences due to changes in living patterns, stress, and old age. Market Segmentation by Geography • North America o USA o Canada • Europe o Germany o France o UK o Spain o Italy • APAC o Japan o China o India o South Korea o Australia • Latin America o Brazil o Mexico • MEA o Turkey o South Africa o Saudi Arabia Insights by Vendors The global cardiac pacemaker market is highly competitive and characterized by the presence of vendors offering a wide range of advanced and innovative cardiac pacemakers. Going forward, R&D activities are expected to become crucial for companies to maintain revenue growth in the coming years. Global players with their huge infrastructure, marketing strategies, distribution network, and R&D support are likely to expand their footprint in the market. Thus, small and emerging vendors find it increasingly difficult to compete with them in terms of innovation, brand image, technology, and price. Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-91016 Key Vendors • Medtronic • Boston Scientific • MicroPort Scientific • Abbott • BIOTRONIK Other Vendors • Galix Biomedical Instrumentation • Lepu Medical • MEDICO • Osypka Medical • OSCOR • Shree Pacetronix • Vitatron Key Market Insights The analysis of the cardiac pacemaker market provides sizing and growth opportunities for the forecast period 2022 - 2031. • Offers sizing and growth prospects of the market for the forecast period 2022 - 2031. • Provides comprehensive insights on the latest industry trends, forecasts, and growth drivers in the market. • Includes a detailed analysis of growth drivers, challenges, and investment opportunities. • Delivers a complete overview of segments and the regional outlook of the market. • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain a competitive advantage. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Surfactants Market Report
The global surfactants market by revenue is expected to grow at a CAGR of over 4.80% during the period 2022 To 2031. Anionic surfactants are witnessing high demand in the global market. Anionic is the most widely used surfactant, contributing 46.31% by value, and are most widely used in cleaning product such as laundering, dishwashing liquids, and shampoo. Increasing demand for agrochemicals and the surge in construction activities are contributing to significant growth for the market in the APAC region. Strong economic growth, demand for green housing, and substantial investment by the federal and state government to boost residential buildings significantly contribute to the growth of the construction chemical and paints and coating in the US, which will drive the demand for surfactants. In recent years, amphoteric surfactants are experiencing rapid development with the rising demand by the end-user. Download The Sample PDF Report Here:- https://www.sdki.jp/sample-request-114893 The following factors are likely to contribute to the growth of the global surfactants market during the forecast period: • Growing Consumption of Bio-Based Surfactants • Increasing Consumption of Surfactants by Cosmetics & Personal Care Segment • Booming Growth of Agrochemical Industry • Growing Food & Beverages Industry The study considers the present scenario of the global surfactants market and its market dynamics for the period 2022 To 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. MARKET SHARE & SEGMENTS • The surge in growth for personal care products and the growing demand for pharmaceutical products are soaring the demand for anionic surfactants. • Surfactants are ubiquitous and one of the vital components of agrochemicals. India, China, Japan, Germany, France, and the UK are the major market for agrochemicals. • The oilfield chemical in the surfactants market is expected to reach USD 2,978.29 million by 2031. • The increasing disposable incomes and growing standard of living create strong demand for surfactants in the textile industry. The global surfactants market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments: Segmentation by Type • Anionic • Non-Ionic • Cationic • Amphoteric • Others Segmentation by End-Use • Household Detergents • Personal Care • Textile • Industrial & Institutional Cleaner • Food Processing • Oilfield Chemicals • Agricultural Chemicals • Construction Chemicals • Pulp & Paper • Others GEOGRAPHICAL ANALYSIS APAC is the largest market for surfactants. Rapid urbanization, rising disposable income, and growing industrialization in food and agriculture are creating a demand for surfactants in APAC. China, India, Japan, and Singapore are the major market for investment in the past couple of years and will continue to be significant. In 2020, China held the largest APAC surfactants market, with a share of 55.80%. Players are shifting their production base to APAC due to the stringent regulatory norms in Europe and North America. Increasing investment in several projects such as 5G networks, artificial intelligence, IoT, and data centers are some of the factors contributing to the rapid growth of the construction industry in China, leading to the high demand for surfactants. Recent changes occurred due to the pandemic, especially in India, the launch of the campaign such as “Vocal for Local” is expected to add momentum to the emergence of India as a leading region. Request The Free Sample PDF Report Here: https://www.sdki.jp/sample-request-114893 Segmentation by Geography • North America o US o Canada • APAC o China o India o Japan o South Korea • Latin America o Brazil o Mexico • Middle East & Africa o Saudi Arabia o UAE o South Africa • Europe o Germany o France o Italy o Netherland o Spain o Belgium COMPETITIVE LANDSCAPE The prominent players in the market focus on developing innovative products to support sustainable development and expanding their product portfolio by making considerable investments in R&D. Mergers and acquisitions, benefiting the companies in purchasing raw materials, distribution, and R&D and it is largely driven by amalgamation. Vendors are delivering specialty chemicals for multiple end-user industries to overcome the competition. The growth of the market in China is bringing strength to the Chinese chemical industry, thus driving the overall growth of the surfactant industry. Vendors are competing to achieve a high share and presence in the global industry. Prominent Vendors • BASF SE • The Lubrizol Corporation • Evonik • Clariant • Arkema Other Prominent Vendors • Solvay • Eastman Chemical Company • Aarti Surfactants • Lonza • Stepan Company • ASHLAND • Croda International PLC • Adeka Corporation • Akchemtech • Alzo International INC. • colonial chemical • Oxiteno • Sanyo Chemical Industries • DOW • Innospec KEY QUESTIONS ANSWERED: 1. What is the growth rate of the surfactants market? 2. Which end-user segment accounts for the largest surfactants market share? 3. Who are the key players in the surfactants market? 4. Which regions in the surfactant industry are more appealing to vendors? 5. What are the major trends that are driving the surfactant market? In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Smart Coatings Market Report
The global smart coatings market by revenue is expected to grow at a CAGR of over 18% during 2022 To 2031. APAC expects to witness the highest incremental growth of over 178% during 2022 To 2031. The availability of inexpensive labor and the easy accessibility of raw materials have shifted the attention of global automotive manufacturers toward the region, which indirectly influence the smart coatings market share. Marine, consumer electronics, and automotive industries are driving the demand from China. China accounts for approximately 90% of shipbuilding activities globally; hence the demand for anti-fouling and anti-corrosive coatings is expected to be reasonably high. Owing to rapid industrialization and foreign investments, China expects to be a significant growth driver in the region. However, the APAC infrastructure sector, which has been affected by the outbreak of the COVID-19 pandemic, has witnessed unprecedented disruptions, leading to the decline in the development of major infrastructure and construction activities. Owing to the pandemic, the government has mandated lockdowns that have further slowed down the development of infrastructure and construction projects. However, construction and infrastructure activities are likely to increase in India and China from mid-2021, thereby offering an impetus to the smart coating market. The following factors are likely to contribute to the growth of the smart coatings market during the forecast period: • Corrosion Indication and Prevention • Growing Demand from Automotive Industry • Superior Properties of Smart Coatings Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-114843 The study considers the global smart coating market’s present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. Global Smart Coatings Market Segmentation The global smart coatings market research report includes a detailed segmentation by layer, function type, end-user, and geography. The global single-layer smart coatings market expects to reach over USD 5 billion by 2026, growing at a CAGR of over 16% during the forecast period. These are widely used in the automotive and aerospace industries. Single-layer anti-reflective coatings are one of the key factors for developing the efficiency of solar cells. Hence, the increasing application of solar cells for the production of electric current is likely to increase the usage of single-layer technology. Self-cleaning and antimicrobial sectors are likely to grow at CAGRs of over 19% during 2022 To 2031. Several industries widely adopt smart self-cleaning coatings to improve the usability and functionality of materials. These are applied on solar panels, glass windows, stain-resistant textiles, corrosion prevention, and anti-biofouling surfaces to ease the cleaning process. Self-cleaning surfaces are extremely water repellent, which increases the lifespan of several metals. Advances in nanotechnology have led to the development of high resilient surfaces, which are resistant to wear and tear and can be used in a wide range of applications. Antimicrobial coatings prevent the growth of pathogens, bacteria, and microbes. A rising number of hospital-acquired infections (HAI) and the outbreak of the COVID-19 pandemic have increased the demand for antimicrobial in several end-user industries such as healthcare institutions, industrial buildings, and the packaging industry. Advanced research and innovations are likely to develop safe, effective, and innovative smart antimicrobial products. The demand for antimicrobial medical coatings is growing from North America and Europe due to growth in HAIs. Automotive, transportation, marine, construction, aerospace & defense, and healthcare are the primary end-user industries. The automotive sector accounted for over 20%, followed by aerospace (over 16%) and consumer electronics (over 15%). The demand from the automotive and transportation sectors will drive the market due to the increased application of smart coatings on door closures, lock parts, exhausts, suspensions, engine components, and clamps & hose connections. In addition, the demand expects to increase in the APAC region due to increasing manufacturing activities. Layer Type • Single Layer • Multi-Layer Function Type • Anticorrosion • Antimicrobial • Anti-Fouling • Self-Healing • Self-Cleaning • Anti-Icing End-user • Automotive • Aerospace • Consumer electronics • Construction • Marine • Healthcare • Others Download the Sample PDF Report Here:- https://www.sdki.jp/sample-request-114843 INSIGHTS BY GEOGRAPHY The APAC region accounted for the largest market for smart coatings, contributing over 46% to the global market. China, India, and Japan are the major contributors to the market in the region. China accounted for over 27% by value, followed by India and Japan with a revenue share of over 20% and 12%, respectively. The increase in construction, marine, and defense industries investment is a major factor for the high demand for smart coatings in China. The increasing need for energy and maintenance of transportation also fuel the growth of smart coatings in the country. Strong economic growth, coupled with growing construction activities and increasing disposable income, has primarily supported market growth in the region. APAC is also the largest construction industry and will continue to dominate the industry during the forecast period. However, the growth in construction activities declined in H1 2020, mainly due to the slowdown of construction in China and other key Asian countries, which was further worsened due to the COVID-19 outbreak. Rapid urbanization and infrastructure development have resulted in the rise of megacities in the region’s fast-growing economies. Geography • North America o US o Canada • Europe o UK o Germany o France o Russia o Spain o Italy • APAC o China o Japan o South Korea o India o Indonesia o Thailand o Australia o Singapore • Latin America o Brazil o Mexico • Middle East & Africa o Saudi Arabia o UAE o South Africa INSIGHTS BY VENDORS Sherwin -Williams, AkzoNobel, PPG Industries, 3M, and Axalta Coating Systems are the major players in the smart coatings market. These companies are at the forefront of delivering innovative and high-quality smart coatings. Companies have increased their R&D expenditure and are focusing on developing environment-friendly materials that are less toxic and have no health hazards. Small vendors such as Protech Oxyplast, Prism Surface Coatings, Kastus technologies are also focusing on capitalizing the product portfolio that suits domestic demands and requirements. The market has been witnessing a spree of mergers and acquisitions over the past decade. Most manufacturers have adopted waterborne, high solids, powder coatings, and UV cure coatings. Prominent Vendors • AkzoNobel NV • Sherwin-Williams • Axalta Coating Systems • PPG Industries • RPM International Inc. Other Prominent Vendors • DSM • 3M • Hempel • Jotun • AK Coatings • Ancatt • Autonomic Materials • Diamond Vogel • Specialty Coating System • Silco Tek • Dow Silicon Corporation • NEI Corporation • Clariant • Parker Hannifin • Dupont • Sciessent • SABIC • Polygiene AB • Parx Material NV • Optical Coating Technologies • Acciona • Burke Industrial Coating • Fiberlock Technologies • Flora Coatings LLC • Nano – Carre Deutschland • Aereus Technologies • Protech Oxyplast • Prism Surface Coating • John Desmond Limited • Innovative Chemical Product (ICP) Group • Sono -Tek Corporation • Jamestown Coating Technologies • Weilburger • Kastus Technologies KEY QUESTIONS ANSWERED: 1. How big is the smart coatings market? 2. What growth rate the smart coating market is likely to grow during the forecast period? 3. Who are the key players in the smart coatings market? 4. Which region witnessed the largest share in the smart coatings market in 2022? 5. What are the key factors driving the smart coatings market? 6. Which layer type is projected to grow at the highest rate? In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Antimicrobial Coatings Market Report
The global antimicrobial coatings market by revenue is expected to grow at a CAGR of approx. 6% during 2022 To 2031. The outbreak of the COVID-19 pandemic has significantly influenced the market. The demand for antimicrobial coating from the healthcare industry has increased drastically to prevent the spread of hospital-acquired infections (HAIs) during the pandemic. Over 2 million people are affected, and 90,000 people die annually due to HAIs, thereby emerging as a major cause of mortality across the world. With the healthcare industry set to cross over the USD 200 billion mark due to the growth of smart hospitals and medical tourism, the demand for advanced medical equipment and surgical procedures increases, thereby increasing the application at a rapid pace. The following factors are likely to contribute to the growth of the antimicrobial coatings market during the forecast period: • High Demand from Healthcare Sector • Increasing Demand from Construction Sector • High Demand from Food Industry • Growing Emergence of New Technologies The study considers the global antimicrobial coating market’s present scenario and its market dynamics for the period 2022 To 2031. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-114832 Global Antimicrobial Coatings Market Segmentation The global antimicrobial coatings market research report includes a detailed segmentation by material type, end-user, and geography. The global silver material market expects to reach over USD 3 billion by 2031. Silver metals are heavily used in various end-user industries, which contribute over 54% of the market share by value. They are used in antimicrobial coating due to the broad continuum of antibacterial, antifungal, antiviral properties, less toxicity, high efficiency, and long-lasting effect. In addition, they show low cytotoxicity and immunological response. Therefore, silver nanoparticles are used in the biomedical sector on a wider scale. These materials are finding high applications in medical tomography, molecular diagnostics, and therapeutics such as fabrication of artificial joint replacements, wound dressing, and surgical wire. The healthcare antimicrobial coatings market is expected to reach over USD 3 billion by 2031, growing at a CAGR of over 7%. The segment accounted for over 54% of the market share in 2022. The healthcare industry is one of the largest end-users. The increasing awareness of hygiene and health safety, growing HAIs cases, and steady increase in chronic orders are stimulating the demand in the healthcare sector. High-touch surfaces in hospitals such as surgical equipment, lift buttons, bedside railings, and IV poles are coated with antimicrobial solutions to prevent the growth of microbes. Currently, North America is the leading market in the application of the antimicrobial medical device coating industry; however, APAC is the fastest-growing region. Material Type • Silver • Copper • Zinc • Titanium Dioxide • Others End-user Industry • Healthcare • Construction • Food Industry • HVAC • Transportation • Others INSIGHTS BY GEOGRAPHY North America dominated the antimicrobial coatings market share of approx. 38% in 2022. The US and Canada are the major end-users in North America and accounted for a revenue share of approx. USD 2 billion in 2022. Owing to the growth of HAIs and the steady rise in chronic diseases, the region is expected to grow at the fastest CAGR of over 6% from 2022 to 2031. Furthermore, the growth in residential and commercial construction activities, the demand for safe and hygienic food, and stringent regulations for installing HVAC systems in buildings are likely to boost the demand in North America. In terms of revenue, APAC accounted for over 18% market share in 2022. The region is the fastest-growing market for antimicrobial coating and is expected to increase its demand in the coming years. The rise in the geriatric population, the increase in healthcare expenditure, and the high adoption of antimicrobial solutions in several end-user industries such as construction, healthcare, textile, and food & processing industry are the primary factor responsible for the market’s growth. China, India, and Japan are the key contributors to the APAC antimicrobial coatings market. China accounts for over 25% share of the market. The demand for antimicrobial coating in China is driven by the healthcare, building & construction, textile, and oil & gas industry. Geography • North America o US o Canada • Europe o UK o Germany o France o Russia o Spain • APAC o China o Japan o South Korea o India o Indonesia o Thailand • Latin America o Brazil o Mexico • Middle East & Africa o Saudi Arabia o UAE o South Africa Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-114832 INSIGHTS BY VENDORS Sherwin -Williams, Akzo Nobel NV, PPG Industries, RPM International, and Axalta Coating Systems are the major players in the antimicrobial coatings market and constitute the maximum share of the market. These companies are at the forefront of delivering innovative and high-quality solutions. Companies have started focusing on sustainability with a commitment to generate more value from fewer resources and turn environmental challenges and societal concerns into product innovations. Several new players entered the antimicrobial coating market with the onset of the COVID-19 pandemic. They expect to expand their presence worldwide during the forecast period, especially in the fast-developing countries in the APAC region, to gain more market share. Prominent Vendors • AkzoNobel NV • Axalta Coating System • PPG Industries • Sherwin- Williams • RPM International Inc. Other Prominent Vendors • BASF • Lonza • DowDuPont • Scissent • Burke Industrial Coating • Fiberlock Technologies • Flora Coatings • Nano-Care • Aereus Technologies • Protech-Oxyplast Group (Protech-Oxyplast Powder Coatings) • IBC Coating Technologies • Prism Surface Coating • John Desmond Ltd. • Innovative Chemical Product Group (ICP) • Sono -Tek Corporation • Diamond Vogel • Jamestown Coating Technologies • Weilburger • Kastus • AST Products • BioInteraction • Hydromer • Jotun Group • Inspiraz Technology Pte Ltd • MVX Hitech KEY QUESTIONS ANSWERED 1. What will be the worth of the global antimicrobial coatings market by the end of 2026? 2. How has the COVID-19 pandemic affected the antimicrobial coatings market? 3. What are the major drivers influencing the growth of the antimicrobial coatings market? 4. Who are the top players in the antimicrobial device coatings market? 5. Who are the major end-users for antimicrobial coatings? |